{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:41:41Z","timestamp":1781534501871,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"STI2030-Major Projects","award":["2021ZD0200800"],"award-info":[{"award-number":["2021ZD0200800"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Niacin Skin-Flushing Response (NSR) has emerged as a promising objective biomarker for the precise diagnosis of mental disorders. However, its diagnostic potential has been constrained by the limitations of traditional statistical approaches. The advent of Artificial Intelligence (AI) offers a transformative opportunity to overcome these challenges. This study presents a novel contribution to the field by establishing an open-access dataset and developing advanced AI-driven tools to enhance the diagnostic accuracy of psychiatric disorders through NSR analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This study introduces the world\u2019s first open dataset specifically developed for AI studies of Niacin Skin-Flushing Response (NSR), a physiological biomarker associated with mental illnesses including depression, bipolar disorder, and schizophrenia. Leveraging this dataset, we developed an advanced Machine Learning (ML) approach designed for the broad diagnosis of mental disorders. Distinct from prior studies which are often limited to First Episode Schizophrenia and depend on specific devices, our approach champions device independence. The core of our methodology involves a novel algorithm featuring an Efficient-Unet based Deep Learning model for the precise segmentation of NSR areas. This segmentation is significantly enhanced by runtime data augmentation and trained on a robust train\/validation\/test dataset split. Subsequently, a Support Vector Machine (SVM) method is employed for psychiatric disorder classification utilizing feature vectors extracted from the segmentation of NSR areas with a 3-scale quantization. The SVM training incorporates 5-fold cross-validation, Synthetic Minority Over-sampling Technique (SMOTE) for managing class imbalance, and hyperparameter tuning to optimize balanced accuracy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The established dataset comprises 600 high-quality NSR images from 120 individuals, encompassing a diverse cohort of healthy controls and patients with various mental illnesses. The developed AI tools offer an objective, swift, and highly accurate approach that is demonstrably independent of the diagnosed condition or the specific device used for image acquisition. Comparative results demonstrate that the ML-based diagnostic approach achieves a sensitivity ranging from 60.0 to 65.0% and a specificity from 75.0 to 88.3% across various types of illnesses, further underscoring its broad applicability and device independence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This research conclusively demonstrates the significant potential of advanced AI tools in achieving precise diagnosis of psychiatric disorders, potentially surpassing human capabilities in both speed and accuracy. With the provision of the proposed open dataset and the introduction of novel methodologies, this study marks substantial progress in developing an objective and accurate NSR-based screening process for a wide spectrum of psychiatric disorders. Its enhanced applicability and independence from specific devices hold profound potential to substantially advance mental health diagnostics and contribute to improved patient outcomes globally.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12888-025-07196-2","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T16:30:48Z","timestamp":1754325048000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["An open dataset and machine learning algorithms for Niacin Skin-Flushing Response based screening of psychiatric disorders"],"prefix":"10.1186","volume":"25","author":[{"given":"Xuening","family":"Lyu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimsa","family":"Goperma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunling","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"issue":"2","key":"7196_CR1","first-page":"54","volume":"32","author":"DF Horrobin","year":"1980","unstructured":"Horrobin DF. Schizophrenia: a biochemical disorder? Biomedicine. 1980;32(2):54\u20135.","journal-title":"Biomedicine"},{"issue":"1","key":"7196_CR2","first-page":"14","volume":"22","author":"S Nadalin","year":"2010","unstructured":"Nadalin S, Buretic-Tomljanovic A, Rubesa G, Tomljanovic D, Gudelj L. Niacin skin flush test: a research tool for studying schizophrenia. Psychiatr Danub. 2010;22(1):14\u201327.","journal-title":"Psychiatr Danub"},{"issue":"4","key":"7196_CR3","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/schbul\/sbx150","volume":"44","author":"LY Sun","year":"2018","unstructured":"Sun LY, Yang XH, Jiang J, Hu XW, Qing Y, Wang DD, Yang TQ, Yang C, Zhang J, Yang P, et al. Identification of the Niacin-Blunted subgroup of schizophrenia patients from mood disorders and healthy individuals in Chinese population. Schizophr Bull. 2018;44(4):896\u2013907.","journal-title":"Schizophr Bull"},{"issue":"1","key":"7196_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/09540260500064959","volume":"17","author":"L Kempf","year":"2005","unstructured":"Kempf L, Hussain N, Potash JB. Mood disorder with psychotic features, schizoaffective disorder, and schizophrenia with mood features: trouble at the borders. Int Rev Psychiatry. 2005;17(1):9\u201319.","journal-title":"Int Rev Psychiatry"},{"issue":"3","key":"7196_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0920-9964(97)00100-X","volume":"29","author":"PE Ward","year":"1998","unstructured":"Ward PE, Sutherland J, Glen EM, Glen AI. Niacin skin flush in schizophrenia: a preliminary report. Schizophr Res. 1998;29(3):269\u201374.","journal-title":"Schizophr Res"},{"key":"7196_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.schres.2021.02.009","volume":"230","author":"DD Wang","year":"2021","unstructured":"Wang DD, Hu XW, Jiang J, Sun LY, Qing Y, Yang XH, Gao Y, Cui GP, Li MH, Wang PK, et al. Attenuated and delayed niacin skin Flushing in schizophrenia and affective disorders: A potential clinical auxiliary diagnostic marker. Schizophr Res. 2021;230:53\u201360.","journal-title":"Schizophr Res"},{"issue":"1","key":"7196_CR7","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/schbul\/sbl038","volume":"33","author":"SH Lin","year":"2007","unstructured":"Lin SH, Liu CM, Chang SS, Hwu HG, Liu SK, Hwang TJ, Hsieh MH, Guo SC, Chen WJ. Familial aggregation in skin flush response to niacin patch among schizophrenic patients and their nonpsychotic relatives. Schizophr Bull. 2007;33(1):174\u201382.","journal-title":"Schizophr Bull"},{"issue":"2","key":"7196_CR8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/schbul\/sbv130","volume":"42","author":"JK Yao","year":"2016","unstructured":"Yao JK, Dougherty GG Jr., Gautier CH, Haas GL, Condray R, Kasckow JW, Kisslinger BL, Gurklis JA, Messamore E. Prevalence and specificity of the abnormal niacin response: A potential endophenotype marker in schizophrenia. Schizophr Bull. 2016;42(2):369\u201376.","journal-title":"Schizophr Bull"},{"issue":"3","key":"7196_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0920-9964(02)00311-0","volume":"62","author":"E Messamore","year":"2003","unstructured":"Messamore E, Hoffman WF, Janowsky A. The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study. Schizophr Res. 2003;62(3):251\u20138.","journal-title":"Schizophr Res"},{"issue":"6","key":"7196_CR10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.plefa.2005.02.007","volume":"72","author":"S Smesny","year":"2005","unstructured":"Smesny S, Rosburg T, Riemann S, Baur K, Rudolph N, Berger G, Sauer H. Impaired niacin sensitivity in acute first-episode but not in multi-episode schizophrenia. Prostaglandins Leukot Essent Fat Acids. 2005;72(6):393\u2013402.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"issue":"3","key":"7196_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0022-3956(03)00006-2","volume":"37","author":"S Smesny","year":"2003","unstructured":"Smesny S, Berger G, Rosburg T, Riemann S, Riehemann S, McGorry P, Sauer H. Potential use of the topical niacin skin test in early psychosis -- a combined approach using optical reflection spectroscopy and a descriptive rating scale. J Psychiatr Res. 2003;37(3):237\u201347.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"7196_CR12","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12888-024-05728-w","volume":"24","author":"J Feng","year":"2024","unstructured":"Feng J, Min W, Wang D, Yuan J, Chen J, Chen L, Chen W, Zhao M, Cheng J, Wan C, et al. Potential of niacin skin flush response in adolescent depression identification and severity assessment: a case-control study. BMC Psychiatry. 2024;24(1):290.","journal-title":"BMC Psychiatry"},{"issue":"2","key":"7196_CR13","doi-asserted-by":"publisher","first-page":"e100753","DOI":"10.1136\/gpsych-2022-100753","volume":"35","author":"T Chen","year":"2022","unstructured":"Chen T, Liu H, Tian R, Gan R, Xu W, Zhang T, Wang J. Artificial intelligence-assisted niacin skin flush screening in early psychosis identification and prediction. Gen Psychiatr. 2022;35(2):e100753.","journal-title":"Gen Psychiatr"},{"key":"7196_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.schres.2022.07.017","volume":"248","author":"Y Qing","year":"2022","unstructured":"Qing Y, Liang J, Wang J, Wan C, Ke X. Attenuated niacin skin Flushing response in children and adolescents with mental disorders: A transdiagnostic early warning marker. Schizophr Res. 2022;248:32\u20134.","journal-title":"Schizophr Res"},{"issue":"2","key":"7196_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/schbul\/sbae066","volume":"51","author":"T Zhang","year":"2025","unstructured":"Zhang T, Xu L, Wei Y, Cui H, Tang X, Hu Y, Tang Y, Wang Z, Liu H, Chen T, et al. Advancements and future directions in prevention based on evaluation for individuals with clinical high risk of psychosis: insights from the SHARP study. Schizophr Bull. 2025;51(2):343\u201351.","journal-title":"Schizophr Bull"},{"key":"7196_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jpsychires.2025.02.059","volume":"184","author":"H Chen","year":"2025","unstructured":"Chen H, Li S, Gu Y, Liang K, Li Y, Cheng B, Jiang Z, Hu X, Wang J, Wang T, et al. Blunted niacin skin Flushing response in violent offenders with schizophrenia: A potential auxiliary diagnostic biomarker. J Psychiatr Res. 2025;184:249\u201355.","journal-title":"J Psychiatr Res"},{"key":"7196_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jad.2022.12.017","volume":"324","author":"J Wang","year":"2023","unstructured":"Wang J, Qing Y, Liang J, Cui G, Wang Q, Zhang J, Yang X, Li M, Wang D, Fan Z, et al. Identification of adolescent patients with depression via assessment of the niacin skin Flushing response. J Affect Disord. 2023;324:69\u201376.","journal-title":"J Affect Disord"},{"issue":"6","key":"7196_CR18","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1742-1241.2001.tb11065.x","volume":"55","author":"BK Puri","year":"2001","unstructured":"Puri BK, Easton T, Das I, Kidane L, Richardson AJ. The niacin skin flush test in schizophrenia: a replication study. Int J Clin Pract. 2001;55(6):368\u201370.","journal-title":"Int J Clin Pract"},{"key":"7196_CR19","doi-asserted-by":"crossref","unstructured":"Baydili I, Tasci B, Tasci G. Deep Learning-Based detection of depression and suicidal tendencies in social media data with feature selection. Behav Sci (Basel) 2025;15(3):352\u201379.","DOI":"10.3390\/bs15030352"},{"key":"7196_CR20","doi-asserted-by":"crossref","unstructured":"Baydili I, Tasci B, Tasci G. Artificial intelligence in psychiatry: A review of biological and behavioral data analyses. Diagnostics (Basel) 2025;15(4):434\u201367.","DOI":"10.3390\/diagnostics15040434"},{"key":"7196_CR21","doi-asserted-by":"crossref","unstructured":"Sitarz R, Juchnowicz D, Karakula K, Forma A, Baj J, Rog J, Karpinski R, Machrowska A, Karakula-Juchnowicz H. Niacin skin flush Backs-From the roots of the test to nowadays hope. J Clin Med 2023;12(5):1879\u201394.","DOI":"10.3390\/jcm12051879"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07196-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-07196-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07196-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T13:51:58Z","timestamp":1757339518000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-025-07196-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7196"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-07196-2","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"31 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. The study uses data collected by Bio-X Institutes, Shanghai Jiao Tong University, which was approved by the ethics committee of Bio-X Institutes, Shanghai Jiao Tong University (ML2019041). All participants signed informed consent forms. Patients or the public were not involved in the design, or conduct, or reporting, or dissemination plans of our research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"757"}}